Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab

Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Case Rep
Hlavní autoři: Venkatesh, Samantha, Al-Haseni, Ali, Sahni, Debjani
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/
https://ncbi.nlm.nih.gov/pubmed/31377718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky